Redmile Group, LLC Ngm Biopharmaceuticals Inc Transaction History

Redmile Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$13.81 - $18.6 $8.05 Million - $10.8 Million	-582,805 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$17.26 - $22.02 $33.2 Million - $42.3 Million	-1,922,313 Reduced 76.74%	582,805 $10.3 Million
Q3 2021 Nov 15, 2021	SELL	$20.15 - $26.19 $5.79 Million - $7.53 Million	-287,330 Reduced 10.29%	2,505,118 $52.7 Million
Q2 2021 Aug 16, 2021	BUY	$15.06 - $30.03 $611,932 - $1.22 Million	40,633 Added 1.48%	2,792,448 $55.1 Million
Q1 2021 May 17, 2021	BUY	$24.99 - $31.93 $68.8 Million - $87.9 Million	2,751,815 New	2,751,815 $80 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.